Details for New Drug Application (NDA): 073357
✉ Email this page to a colleague
NDA 073357 describes AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE, which is a drug marketed by Barr, Chartwell Rx, Rising, Teva, and Watson Labs, and is included in five NDAs. It is available from two suppliers. Additional details are available on the AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE profile page.
The generic ingredient in AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE is amiloride hydrochloride; hydrochlorothiazide. There are five drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the amiloride hydrochloride; hydrochlorothiazide profile page.
The generic ingredient in AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE is amiloride hydrochloride; hydrochlorothiazide. There are five drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the amiloride hydrochloride; hydrochlorothiazide profile page.
Summary for 073357
| Tradename: | AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE |
| Applicant: | Chartwell Rx |
| Ingredient: | amiloride hydrochloride; hydrochlorothiazide |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | EQ 5MG ANHYDROUS;50MG | ||||
| Approval Date: | Nov 27, 1991 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
